Northrop Grumman Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings
07/21

Northrop Grumman Corporation (NYSE:NOC) will release its second quarter earnings report before the opening bell on Tuesday, July 21.

Analysts expect the Falls Church, Virginia-based company to report quarterly earnings of $6.82 per share, down from $8.15 per share in the year-ago period. The consensus estimate for Northrop Grumman’s quarterly revenue is $10.8 billion. It reported $10.35 billion last year, according to Benzinga Pro.

On April 21, Northrop Grumman posted upbeat first-quarter earnings.

Shares of Northrop Grumman gained 0.5% to close at $523.96 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Goldman Sachs analyst Noah Poponak maintained a Neutral rating and cut the price target from $603 to $533 on July 14, 2026. This analyst has an accuracy rate of 65%.
  • TD Cowen analyst Gautam Khanna maintained a Hold rating and lowered the price target from $680 to $580 on July 13, 2026. This analyst has an accuracy rate of 74%.
  • Citigroup analyst John Godyn maintained a Buy rating and cut the price target from $628 to $587 on July 1, 2026. This analyst has an accuracy rate of 52%.
  • Jefferies analyst Sheila Kahyaoglu maintained a Hold rating and cut the price target from $620 to $580 on June 26, 2026. This analyst has an accuracy rate of 73%.
  • UBS analyst Gavin Parsons maintained a Buy rating and slashed the price target from $806 to $745 on April 23, 2026. This analyst has an accuracy rate of 66%

Considering buying NOC stock? Here’s what analysts think:

Photo via Shutterstock

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10